See the source article by following the link below:
Humans have pre-existing immune defenses against some of the most widely used forms of CAS9 a new study shows. This may ultimately mean it will be harder than first thought to clinically translate CRISPR-CAS9 technology to treat genetic based disease.
Humans have pre-existing immune defenses against some of the most widely used forms of CAS9 a new study shows. This may ultimately mean it will be harder than first thought to clinically translate CRISPR-CAS9 technology to treat genetic based disease.
No comments:
Post a Comment